ICU Medical Valuation
| ICUI Stock | USD 167.81 0.65 0.39% |
At this time, the entity appears to be undervalued. ICU Medical retains a regular Real Value of $185.23 per share. The prevalent price of the entity is $167.81. Our model calculates the value of ICU Medical from analyzing the entity fundamentals such as return on asset of 0.0066, and Operating Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ICU Medical's valuation include:
Price Book 2.0134 | Enterprise Value 5.5 B | Enterprise Value Ebitda 24.8904 | Price Sales 1.7626 | Forward PE 22.5734 |
Undervalued
Today
Please note that ICU Medical's price fluctuation is very steady at this time. Calculation of the real value of ICU Medical is based on 3 months time horizon. Increasing ICU Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ICU Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ICU Stock. However, ICU Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 167.81 | Real 185.23 | Target 200.0 | Hype 168.33 | Naive 165.17 |
The intrinsic value of ICU Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence ICU Medical's stock price.
Estimating the potential upside or downside of ICU Medical helps investors to forecast how ICU stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ICU Medical more accurately as focusing exclusively on ICU Medical's fundamentals will not take into account other important factors: When choosing an evaluation method for ICU Medical, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
ICU Medical Cash |
|
ICU Valuation Trend
ICU Medical's real value analysis enables investors to forecast the earnings more efficiently. Using both ICU Medical's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
ICU Revenue by Product
ICU Medical Total Value Analysis
ICU Medical is currently anticipated to have valuation of 5.47 B with market capitalization of 4.12 B, debt of 1.7 B, and cash on hands of 285.59 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ICU Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.47 B | 4.12 B | 1.7 B | 285.59 M |
ICU Medical Investor Information
About 92.0% of the company shares are owned by institutional investors. The book value of ICU Medical was currently reported as 83.76. The company has Price/Earnings To Growth (PEG) ratio of 1.7. ICU Medical recorded a loss per share of 4.57. The entity had not issued any dividends in recent years. The firm had 3:2 split on the 18th of March 2002. Based on the analysis of ICU Medical's profitability, liquidity, and operating efficiency, ICU Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.ICU Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of ICU signifies not a very effective usage of assets in November.ICU Medical Ownership Allocation
The majority of ICU Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in ICU Medical to benefit from reduced commissions. Therefore, third-party entities are subject to a different set of regulations than regular investors in ICU Medical. Please pay attention to any change in the institutional holdings of ICU Medical as this could imply that something significant has changed or is about to change at the company. On November 7, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of ICU Medical's common stock.ICU Medical Profitability Analysis
The company reported the previous year's revenue of 2.26 B. Net Loss for the year was (29.66 M) with profit before overhead, payroll, taxes, and interest of 697.76 M.About ICU Medical Valuation
An absolute valuation paradigm, as applied to ICU Stock, attempts to find the value of ICU Medical based on its fundamental and basic technical indicators. By analyzing ICU Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ICU Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ICU Medical. We calculate exposure to ICU Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ICU Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 739.9 M | 776.9 M | |
| Pretax Profit Margin | (0.03) | (0.03) | |
| Operating Profit Margin | 0.01 | 0.01 | |
| Net Loss | (0.01) | (0.01) | |
| Gross Profit Margin | 0.33 | 0.56 |
ICU Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 24.1 M | |
| Quarterly Earnings Growth Y O Y | -0.238 | |
| Forward Price Earnings | 22.5734 |
ICU Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of ICU Medical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ICU we look at many different elements of the entity such as ICU's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ICU Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ICU Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ICU Medical's worth.Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |